Selecta Biosciences Receives $4,450,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b6cd9c98-feb6-4e65-bb05-41a5a3985869
Date
8/29/2014
Company Name
Selecta Biosciences
Mailing Address
480 Arsenal St. Building One Watertown, MA 02472 USA
Company Description
Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications.
Website
http://www.selectabio.com
Transaction Type
Venture Equity
Transaction Amount
$4,450,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor